Key facts
- This page summarizes Scott T. Garrett's Form 4 filing for HCW Biologics Inc. (HCWB).
- 1 reported transaction and 1 derivative row are listed below.
- Accepted by SEC: 17 Jun 2024, 16:58.
Key filing fact
Ownership activity is grounded in SEC Form 4 disclosures.
Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.
Award
Additional SEC filing notes
Footnote F1
(1) 100% of the total number of shares subject to the Option shall vest and become exercisable on the earlier of (a) June 13, 2025 or (b) the next annual meeting of stockholders, subject to the Reporting Person continuing to provide services through the vesting date.